PDS Biotechnology Corporation (PDSB) Operating cash flow 2016–2025
PDS Biotechnology Corporation (PDSB) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$27.8MFY2025 · since FY2016: -$32.2M → -$27.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$27.8M | +20.8% |
| FY2024 | -$35.0M | -4.1% |
| FY2023 | -$33.6M | -30.8% |
| FY2022 | -$25.7M | -105.9% |
| FY2021 | -$12.5M | +5.0% |
| FY2020 | -$13.1M | +27.2% |
| FY2019 | -$18.1M | -1051.5% |
| FY2018 | -$1.6M | +96.1% |
| FY2017 | -$40.7M | -26.4% |
| FY2016 | -$32.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PDSB financial trends
PDSB RevenuePDSB Net incomePDSB Net marginPDSB Gross profitPDSB Gross marginPDSB Operating incomePDSB Operating marginPDSB Free cash flowPDSB Capital expendituresPDSB Return on equityPDSB Stock buybacksPDSB Dividends paidPDSB Total assetsPDSB Total liabilitiesPDSB Shareholders’ equityPDSB overview →